1 |
Wu JJ, Yao M, Ni J. Cerebral amyloid angiopathy-related inflammation: current status and future implications [J]. Chin Med J (Engl), 2021, 134(6): 646-654.
|
2 |
Charidimou A, Boulouis G, Frosch MP, et al. The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study [J]. Lancet Neurol, 21(8): 714-725.
|
3 |
吴娟娟, 倪俊. 脑淀粉样血管病发病机制的研究进展 [J]. 中国卒中杂志, 2021, 16(12): 1278-1283.
|
4 |
Jäkel L, De Kort AM, Klijn CJM, et al. Prevalence of cerebral amyloid angiopathy: a systematic review and meta-analysis [J]. Alzheimers Dement, 2022, 18(1): 10-28.
|
5 |
Koemans EA, Chhatwal JP, van Veluw SJ, et al. Progression of cerebral amyloid angiopathy: a pathophysiological framework [J]. Lancet Neurol, 2023, 22(7): 632-642.
|
6 |
Auger CA, Perosa V, Greenberg SM, et al. Cortical superficial siderosis is associated with reactive astrogliosis in cerebral amyloid angiopathy [J]. J Neuroinflammation, 2023, 20(1): 195.
|
7 |
Ng J, Papandreou A, Heales SJ, et al. Monoamine neurotransmitter disorders--clinical advances and future perspectives [J]. Nat Rev Neurol, 2015, 11(10): 567-584.
|
8 |
Stockwell BR, Friedmann Angeli JP, Bayir H, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease [J]. Cell, 2017, 171(2): 273-285.
|
9 |
Haller S, Haacke EM, Thurnher MM, et al. Susceptibility-weighted imaging: technical essentials and clinical neurologic applications [J]. Radiology, 2021, 299(1): 3-26.
|
10 |
Liu M, Liu S, Ghassaban K, et al. Assessing global and regional iron content in deep gray matter as a function of age using susceptibility mapping [J]. J Magn Reson Imaging, 2016, 44(1): 59-71.
|
11 |
Bilgic B, Pfefferbaum A, Rohlfing T, et al. MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping [J]. Neuroimage, 2012, 59(3): 2625-2635.
|
12 |
Greenberg SM, Charidimou A. Diagnosis of cerebral amyloid angiopathy: evolution of the boston criteria [J]. Stroke, 2018, 49(2): 491-497.
|
13 |
Ward RJ, Zucca FA, Duyn JH, et al. The role of iron in brain ageing and neurodegenerative disorders [J]. Lancet Neurol, 2014, 13(10): 1045-1060.
|
14 |
Sharma B, Beaudin AE, Cox E, et al. Brain iron content in cerebral amyloid angiopathy using quantitative susceptibility mapping [J]. Front Neurosci, 2023, 17: 1139988.
|
15 |
Ayton S, Fazlollahi A, Bourgeat P, et al. Cerebral quantitative susceptibility mapping predicts amyloid-β-related cognitive decline [J]. Brain, 2017, 140(8): 2112-2119.
|
16 |
Chen L, Soldan A, Oishi K, et al. Quantitative susceptibility mapping of brain iron and β-amyloid in MRI and PET relating to cognitive performance in cognitively normal older adults [J]. Radiology, 2021, 298(2): 353-362.
|
17 |
Ayton S, Wang Y, Diouf I, et al. Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology [J]. Mol Psychiatry, 2020, 25(11): 2932-2941.
|
18 |
Ayton S, Portbury S, Kalinowski P, et al. Regional brain iron associated with deterioration in Alzheimer's disease: a large cohort study and theoretical significance [J]. Alzheimers Dement, 2021, 17(7): 1244-1256.
|
19 |
Dadario NB, Sughrue ME. The functional role of the precuneus [J]. Brain, 2023, 146(9): 3598-3607.
|